Close Menu

NEW YORK – Ayala Pharmaceuticals on Friday said it expects to raise $25 million from the sale of 1,666,666 units of equity securities in a private placement with institutional investors, including Redmile Group and SIO Capital Management.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.